The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

The Federal Trade Commission (FTC) has moved to block Edwards Lifesciences’ purchase of JenaValve Technology and its ...

The Federal Trade Commission has moved to block Edwards Lifesciences’ proposed acquisition of medical-device company JenaValve Technology.The FTC said in a complaint filed Wednesday the acquisition ...

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

Investing.com -- Moody’s Ratings has affirmed Edwards Lifesciences Corporation ’s Baa2 ratings while revising the outlook to positive from stable, the credit rating agency announced Wednesday.

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

Edwards bought heart device makers JenaValve Technology and Endotronix in deals valued at about $1.2 billion in July, as it looks to become a pure-play structural heart company.

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...